Phase II study of Gleevec® plus hydroxyurea in adults with progressive or recurrent low-grade glioma()

BACKGROUND: We evaluated the efficacy of imatinib plus hydroxyurea in patients with progressive/recurrent low-grade glioma. METHODS: A total of 64 patients with recurrent/progressive low-grade glioma were enrolled in this single-center study that stratified patients into astrocytoma and oligodendrog...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Reardon, David A., Desjardins, Annick, Vredenburgh, James J., Herndon, James E., Coan, April, Gururangan, Sridharan, Peters, Katherine B., McLendon, Roger, Sathornsumetee, Sith, Rich, Jeremy N., Lipp, Eric S., Janney, Dorothea, Friedman, Henry S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3748946/
https://ncbi.nlm.nih.gov/pubmed/22371319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26541
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items